STOCK TITAN

Molina Healthcare Announces Closing of Offering of $750 Million of 6.250% Senior Notes Due 2033

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags

Molina Healthcare (NYSE: MOH) has completed its previously announced offering of $750 million in senior notes due 2033. The notes carry a 6.250% interest rate, payable semi-annually on January 15 and July 15, starting July 15, 2025. After deducting fees and expenses, the net proceeds amount to approximately $740 million. The company plans to use these funds for general corporate purposes, including debt repayment, acquisitions, share repurchases, capital expenditures, working capital, and capital contributions to its health plan subsidiaries for statutory requirements.

Molina Healthcare (NYSE: MOH) ha completato l'offerta precedentemente annunciata di 750 milioni di dollari in obbligazioni senior con scadenza nel 2033. Le obbligazioni presentano un tasso d'interesse del 6,250%, pagabile semestralmente il 15 gennaio e il 15 luglio, a partire dal 15 luglio 2025. Dopo aver dedotto le spese e le commissioni, il ricavato netto ammonta a circa 740 milioni di dollari. L'azienda prevede di utilizzare questi fondi per scopi aziendali generali, inclusi il rimborso dei debiti, acquisizioni, riacquisto di azioni, spese in conto capitale, capitale circolante e contributi in capitale alle sue sussidiarie di piano sanitario per rispettare i requisiti normativi.

Molina Healthcare (NYSE: MOH) ha completado su oferta previamente anunciada de 750 millones de dólares en notas senior con vencimiento en 2033. Las notas llevan un tasa de interés del 6,250%, pagadera de manera semestral el 15 de enero y el 15 de julio, comenzando el 15 de julio de 2025. Tras deducir tarifas y gastos, el producto neto asciende a aproximadamente 740 millones de dólares. La compañía planea utilizar estos fondos para fines corporativos generales, incluyendo el pago de deudas, adquisiciones, recompra de acciones, gastos de capital, capital de trabajo y contribuciones de capital a sus filiales de planes de salud para cumplir con los requisitos legales.

몰리나 헬스케어 (NYSE: MOH)는 2033년에 만기가 도래하는 7억 5천만 달러의 고위험 채권 공모를 완료했습니다. 이 노트의 이자율은 6.250%이며, 2025년 7월 15일부터 매년 1월 15일과 7월 15일에 반기별로 지급됩니다. 수수료와 비용을 공제한 후, 순수익은 약 7억 4천만 달러에 달합니다. 회사는 이 자금을 일반 기업 용도로 사용할 계획으로, 이는 부채 상환, 인수, 자사주 매입, 자본 지출, 운영 자본, 법적 요구 사항 충족을 위한 건강 계획 자회사에 대한 자본 기여 등을 포함합니다.

Molina Healthcare (NYSE: MOH) a achevé son offre précédemment annoncée de 750 millions de dollars en obligations senior arrivant à échéance en 2033. Les obligations portent un taux d'intérêt de 6,250%, payable semestriellement le 15 janvier et le 15 juillet, à partir du 15 juillet 2025. Après déduction des frais et dépenses, le produit net s'élève à environ 740 millions de dollars. L'entreprise prévoit d'utiliser ces fonds à des fins d'entreprise générale, y compris le remboursement de dettes, des acquisitions, le rachat d'actions, des dépenses d'investissement, du fonds de roulement et des contributions en capital à ses filiales de plans de santé pour répondre aux exigences légales.

Molina Healthcare (NYSE: MOH) hat das zuvor angekündigte Angebot von 750 Millionen US-Dollar in vorrangigen Anleihen mit Fälligkeit im Jahr 2033 abgeschlossen. Die Anleihen haben einen 6,250% Zins, zahlbar halbjährlich am 15. Januar und am 15. Juli, beginnend am 15. Juli 2025. Nach Abzug von Gebühren und Kosten beträgt der Nettobetrag etwa 740 Millionen US-Dollar. Das Unternehmen plant, diese Mittel für allgemeine Unternehmenszwecke zu verwenden, einschließlich Schuldenrückzahlungen, Übernahmen, Aktienrückkäufe, Investitionen, Betriebskapital und Kapitalbeiträge an seine Tochtergesellschaften im Bereich Gesundheitspläne zur Erfüllung gesetzlicher Anforderungen.

Positive
  • Successfully raised $750 million through senior notes offering
  • Strong market access to debt financing
  • Flexible use of proceeds allowing for strategic investments and growth opportunities
Negative
  • Additional debt burden with 6.250% interest rate
  • Increased interest expenses will impact future earnings
  • Net proceeds of $740M represent $10M in fees and expenses

Insights

This $750 million senior notes offering at 6.25% represents a significant debt financing move for Molina Healthcare. The $740 million net proceeds provide substantial financial flexibility for various strategic initiatives. The interest rate, while reflecting current market conditions, is relatively competitive for a healthcare insurer. The 2033 maturity allows for long-term debt structuring.

The semi-annual interest payments starting July 2025 will impact cash flow by approximately $46.9 million annually. The multiple use cases for the proceeds, including potential acquisitions, share repurchases and capital contributions to health plan subsidiaries, indicate a balanced approach to capital allocation. This debt issuance strengthens Molina's financial position but must be monitored in context with their overall leverage ratios and debt service capabilities.

LONG BEACH, Calif.--(BUSINESS WIRE)-- Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the closing of its previously announced offering of $750 million aggregate principal amount of 6.250% senior notes due 2033 (the “Notes”) sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain persons outside the United States in reliance on Regulation S under the Securities Act.

The Notes bear interest at a rate of 6.250% per annum. Interest on the Notes is payable semi-annually in arrears on January 15 and July 15 of each year, commencing July 15, 2025, and accrues from November 18, 2024. The Notes will mature on January 15, 2033.

After deducting fees and expenses payable by the Company, the net proceeds from the issuance and sale of the Notes were approximately $740 million (the “Net Proceeds”). The Company intends to use the Net Proceeds for general corporate purposes, which may include repayment of indebtedness, funding for acquisitions, share repurchases, capital expenditures, additions to working capital and capital contributions to the Company’s health plan subsidiaries to meet statutory requirements in new or existing states.

The Notes have not been registered under the Securities Act or any state securities laws and may not be offered or sold within the United States or to, or for the benefit of, a U.S. person (as defined in Regulation S) except in transactions exempt from, or not subject to, the registration requirements of the Securities Act.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes and shall not constitute an offer, solicitation or sale in any state or jurisdiction where such offer, solicitation or sale is prohibited.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this press release may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “intends,” “will,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this press release include, but are not limited to, statements related to the Company’s offering of the Notes and the intended use of the Net Proceeds of the offering, which are subject to risks and uncertainties, including, without limitation, risks related to market and other general economic conditions. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and it cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of the date hereof, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.

Investor Contact: Jeff Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012

Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588

Source: Molina Healthcare, Inc.

FAQ

What is the interest rate on Molina Healthcare's (MOH) 2033 senior notes?

The senior notes carry an interest rate of 6.250% per annum.

When will Molina Healthcare's (MOH) 2033 senior notes mature?

The notes will mature on January 15, 2033.

How much did Molina Healthcare (MOH) raise in net proceeds from the senior notes offering?

After deducting fees and expenses, Molina Healthcare raised approximately $740 million in net proceeds.

What will Molina Healthcare (MOH) use the proceeds from the senior notes for?

The proceeds will be used for general corporate purposes, including debt repayment, acquisitions, share repurchases, capital expenditures, working capital, and capital contributions to health plan subsidiaries.

Molina Healthcare, Inc.

NYSE:MOH

MOH Rankings

MOH Latest News

MOH Stock Data

16.95B
56.55M
1.13%
99.86%
1.74%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
LONG BEACH